Akumin® · 1 day ago
PETCT TECH
Akumin® is a healthcare company specializing in imaging services, and they are seeking a PET/CT technologist to ensure patient comfort and produce high-quality diagnostic images. The role involves effective communication with patients and radiologists, as well as training new technologists and troubleshooting equipment.
Hospital & Health Care
Responsibilities
Responsible for patient safety including pre-screening for contraindications, aseptic injection technique, etc. and radiation safety/regulations, including proper documentation and technique when working with radioactive materials/patients
Produces high quality diagnostic images
Effectively communicates with customers and/or radiologists
Trains new technologists and/or PC's
Trouble-shoots the scanner, coach and peripheral equipment (including: monitors, PACS, coils, etc.)
Qualification
Required
High School Diploma or equivalent experience required
Certification in Nuclear Medicine by the NMTCB or ARRT (N) required
State license, as required
CPR certification required
As applicable, valid state driver's license
Ability to work at several locations
Strong customer service skills
Organizational and multi-tasking skills
Basic knowledge of computer applications and programs
The COVID-19 vaccination is/may be a condition of employment
All candidates who accept an offer for employment will be required to successfully complete a pre-employment background check and drug screen as a condition of employment
Preferred
Associate's Degree or equivalent experience preferred
1-2 years' experience in Nuclear Medicine procedures and studies preferred
Company
Akumin®
Akumin is a leading U.S.
H1B Sponsorship
Akumin® has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2022 (1)
2020 (3)
Funding
Current Stage
Late StageCompany data provided by crunchbase